Le manifestazioni ematologiche della sindrome da ... - Salute per tutti

116
Scripta MEDICA
Volume 7, n. 4, 2004
immunodeficiency virus. Am J Clin Pathol., 1991; 96:500
85. Nieuwenhuis HK, Sixma JJ. Thrombocytopenia and the
neglected megakaryocyte. N Engl J Med 1992; 327:1812
86. Kouri YH, Borkowsky W, Nardi M, et al. Human
megakaryocytes have a CD4 molecule capable of binding
human immunodeficiency virus-1. Blood 1993; 81:2664
87. Zucker-Franklin D, Cao Y. Megakaryocytes of
human immunodeficiency virus-infected individuals
express viral RNA. Proc. Natl Acad Sci 1989; 5599:5595
88. Louache F, Bettaieb A, Henri A, et al. Infection of
megakaryocytes by human immunodeficiency virus in seropositive
patients with immune thrombocytopenic purpura.
Blood 1991; 78:1679
89. Gascon P, Sathe SS, Rameswar P. Impaired erythropoiesis
in the acquired immunodeficiency syndrome with
disseminated Mycobacterium avium-complex. Am J Med
1993; 94:41
90. Costello C. The haematological manifestations of HIV
disease. In: Posteraduate Haematology. IV Edition: Eds.
Hoffbrand AV, Lewis SM, Tuddenham EGD. Butterworth
Heineman, 1999, p.309
91. Fezoui M, Garnier G, Taillan B, Cassuto JP, Pesce A.
Anomalies de l’hemostase et infection par le virus de l’immunodéficience
humaine. Rev Med Interne 1996; 17:738
92. Bloom EJ, Abrams DI, Rodgers G. Lupus anticoagulant
in the acquired immunodeficiency syndrome. JAMA 1986;
256:491
93. Gold JE, Haubenstock A, Zalusky R. Lupus anticoagulant
and AIDS. N Engl J Med 1986; 314:1252
94. Cohen H, Mackie IJ, Anagnostopoulos N, et al. Lupus
anticoagulant, anticardiolipin antibodies and human immunodeficiency
virus in haemophilia. J Clin Pathol 1989; 42:629
95. Canoso RT, Zon LI, Groopman JE. Anticardiolipin
antibodies with HTLV-III infection. Br J Haemat 1987;
65:495
96. Karp JE, Broder S. Acquired immunodeficiency syndrome
and non Hodgkin’s lymphomas. Cancer Res 1991;
51:4743
97. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, et
al. AIDS-related lymphoma. Histopathology, immunophenotype
and association with Epstein-Barr virus as demonstrated
by in situ nucleic acid hybridisation. Am J Pathol
1991; 138:149
98. Kinlen L. Immunosuppressive therapy and acquired
immunologic disorders. Cancer Res 1992; 52:5474
(suppl. 19)
99. Beral V, Peterman T, Berkelman R, Jaff H. AIDS-associated
non-Hodgkin lymphoma. Lancet 1991; 337:805
100. Lowenthal DA, Straus DJ, Campbell SW, et al.
AIDS-related lymphoid neoplasia: the Memorial Hospital
experience. Cancer 1988; 61:2325
101. Shibata D, Weiss LM, Hernandez AM, et al. Epstein-
Barr virus-associated non-Hodgkin’s lymphoma in patients
infected with the human immunodeficiency virus. Blood
1993; 81:2102
102. Carbone A, Tirelli U, Gloghini A, et al. Human immunodeficiency
virus associated systemic lymphomas may be
subdivided into two main groups according to Epstein-Barr
viral latent gene expression. J Clin Oncol 1993; 11:1674
103. Camilleri-Broet S, David F, Feuillard J, et al. High
expression of latent membrane protein-1 of Epstein-Barr
virus and BCL-2 oncoprotein in acquired immunodeficiency
syndrome-related primary brain lymphomas. Blood
1995; 86:432
104. Ballerini P, Gaidano G, Gong JZ, et al. Multiple
genetic lesions in acquired immunodeficiency syndromerelated
non-Hodgkin’s lymphoma. Blood 1993; 81:166
105. Gaidano G, Lo Coco F, Ye BM, et al. Rearrangements
of the BCL-6 gene in acquired immunodeficiency
syndrome-associated non-Hodgkin’s lymphoma: association
with diffuse large-cell subtype. Blood 1994; 84:397
106. Carbone A, Gloghini A, Vaccher E, et al. Kaposi’s
sarcoma-associated herpes virus DNA sequences in AIDSrelated
and AIDS-unrelated lymphomatous effusions Br J
Haematol 1996; 94:533
107. Boyle MJ, Goldstein DA, Frazer IH, Sculley TB.
Managing HIV, Part 3: mechanisms of disease 3.6 How
HIV promotes malignancies. Med J Aust 1996; 164:230
108. Retting MB, MA HJ, Vescio RA, et al. Kaposi’s sarcoma-associated
herpes virus infection of bone marrow
dendritic cells from multiple myeloma patients. Science
1997; 276:1851
109. Manabe A, Murti KG, Coustan-Smith E, et al.
Adhesion-dependent survival of normal and leukemic
human B lymphoblasts on bone marrow stromal cells.
Blood 1994; 83:758
110. Koopman G, Keehnen RM, Lindhout E, et al.
Adhesion through the LFA-1 (CD11a/CD18)- ICAM-1
(CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106)
pathways prevents apoptosis of germinal centre B cells. J
Immunol 1994; 152:3760
111. Jarvis LJ, Lebien TW. Stimulation of human bone
marrow stromal cell tyrosine kinases and IL-6 production
by contact with B lymphocytes. J Immunol 1995; 155:2359
112. Dittel BN, Mcarthy JB, Wayner EA. Regulation of
human B-cell precursor adhesion in bone marrow stromal
cells by cytokines that exert opposing effects on the expression
of vascular cell adhesion molecule-1 (VCAM-1). Blood
1993; 81:2272
113. Moses AV, Williams SE, Strussenberg JG, et al.
HIV-1 induction of CD40 or endothelial cells promotes the
out growth of AIDS-associated B cell lymphomas. Nature
Med 1997; 3:1242
114. Ryan DH, Nuccie BL, Abboud CN, et al. Vascular
cell adhesion molecule-1 and the integrin VLA-4 mediate
adhesion of human B cell precursors in cultured bone marrow
adherent cells. J Clin Invest 1991; 88:995